Year | Natural | Base-case | WHO | Ideal 1 | Ideal 2 | |||||
---|---|---|---|---|---|---|---|---|---|---|
2030 | 2050 | 2030 | 2050 | 2030 | 2050 | 2030 | 2050 | 2030 | 2050 | |
Total CHB | 73.74 | 43.18 | 73.53 | 43.59 | 68.07 | 27.49 | 67.50 | 27.03 | 67.51 | 27.08 |
Δ CHB | 40.14 | 87.74 | 40.34 | 87.32 | 39.48 | 81.65 | 40.06 | 82.11 | 40.05 | 82.07 |
HBsAg loss | 18.79 | 27.59 | 23.26 | 35.33 | 22.69 | 32.67 | 23.42 | 33.42 | 23.45 | 33.58 |
Percent | 46.81% | 31.45% | 57.65% | 40.46% | 57.47% | 40.01% | 58.46% | 40.70% | 58.55% | 40.92% |
HBV-RD | 13.24 | 27.19 | 9.02 | 16.89 | 8.77 | 15.13 | 8.57 | 14.77 | 8.53 | 14.46 |
Percent | 32.99% | 31.00% | 22.37% | 19.35% | 22.21% | 18.53% | 21.39% | 17.99% | 21.29% | 17.62% |
BD | 8.11 | 32.96 | 8.06 | 35.10 | 8.02 | 33.85 | 8.07 | 33.92 | 8.07 | 34.03 |
Percent | 20.20% | 37.57% | 19.98% | 40.20% | 20.31% | 41.46% | 20.14% | 41.31% | 20.15% | 41.46% |